Ganglioside GM2

Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Ganglioside GM2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ganglioside GM2?

Ganglioside GM2 is suspected in Tay-Sachs Disease, Gangliosidoses GM2, Sandhoff Disease, Neuropathy, Cytomegalovirus Infections, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Ganglioside GM2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ganglioside GM2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ganglioside GM2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ganglioside GM2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ganglioside GM2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ganglioside GM2?

Disease model

Disease model are used in the study 'Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.' (Ho CW et al., 2010) and Disease model are used in the study 'Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.' (Tsuji D et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Ganglioside GM2

Download all related citations
Per page 10 20 50 100 | Total 558
Authors Title Published Journal PubMed Link
Stencel-Baerenwald J et al. Glycan engagement dictates hydrocephalus induction by serotype 1 reovirus. 2015 MBio pmid:25736887
Livingston PO et al. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside. 1989 Cancer Res. pmid:2582446
Baba H et al. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy. 1989 J. Neuroimmunol. pmid:2584393
Rockwell HE et al. AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system. ASN Neuro pmid:25873306
Zvezdina ND et al. Gangliosides of sea urchin embryos. Their localization and participation in early development. 1989 Eur. J. Biochem. pmid:2598928
Caughlin S et al. Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Aβ Toxicity and Stroke. 2015 PLoS ONE pmid:26086081
Anheuser S et al. Membrane lipids regulate ganglioside GM2 catabolism and GM2 activator protein activity. 2015 J. Lipid Res. pmid:26175473
Mahata B et al. GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway. 2015 PLoS ONE pmid:26226135
Sikora J et al. X-linked Christianson syndrome: heterozygous female Slc9a6 knockout mice develop mosaic neuropathological changes and related behavioral abnormalities. 2016 Dis Model Mech pmid:26515654
Yin Z et al. Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies. 2016 Chembiochem pmid:26538065
Spagnoli C et al. CMV-associated axonal sensory-motor Guillain-Barré syndrome in a child: Case report and review of the literature. 2016 Eur. J. Paediatr. Neurol. pmid:26621312
Dotta F et al. Ganglioside expression in human pancreatic islets. 1989 Diabetes pmid:2695376
Kohyama M et al. In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses. 2016 BMC Vet. Res. pmid:27036194
Kundu M et al. Ganglioside GM2 mediates migration of tumor cells by interacting with integrin and modulating the downstream signaling pathway. 2016 Biochim. Biophys. Acta pmid:27066976
Worstell NC et al. Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array. 2016 PLoS ONE pmid:27070150
Riboni L et al. Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b. 1989 J. Neurochem. pmid:2709011
Hoon DS et al. Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells. 1989 Int. J. Cancer pmid:2714890
Karumuthil-Melethil S et al. Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease. 2016 Hum. Gene Ther. pmid:27197548
Tanaka K et al. Enhanced expression of unique gangliosides with GM2-determinant in human uterine cervical carcinoma-derived cell lines. 2016 Glycoconj. J. pmid:27270764
Ishigaki H et al. Childhood-Onset Multifocal Motor Neuropathy With Immunoglobulin M Antibodies to Gangliosides GM1 and GM2: A Case Report and Review of the Literature. 2016 Pediatr. Neurol. pmid:27400822
Jones PC and Irie RF Therapeutic Strategies for Human IgM Antibodies Directed at Tumor-Associated Ganglioside Antigens: Discoveries Made During the Morton Era and Future Directions. 2016 Crit Rev Oncog pmid:27481004
Wolf H et al. A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease. 2016 Dis Model Mech pmid:27491075
Schröder M et al. Isolation of a cDNA encoding the human GM2 activator protein. 1989 FEBS Lett. pmid:2753159
Dufresne M et al. Multimodal detection of GM2 and GM3 lipid species in the brain of mucopolysaccharidosis type II mouse by serial imaging mass spectrometry and immunohistochemistry. 2017 Anal Bioanal Chem pmid:27873002
Trilck M et al. Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons. 2017 Brain Res. pmid:27923633
Ghidoni R et al. Metabolism of exogenous gangliosides in cerebellar granule cells, differentiated in culture. 1989 J. Neurochem. pmid:2795018
Cavaillon JM et al. Ganglioside identification on human monocyte membrane with Clostridium perfringens delta-toxin. 1986 J. Leukoc. Biol. pmid:2872258
Suzuki KGN et al. Development of new ganglioside probes and unraveling of raft domain structure by single-molecule imaging. 2017 Biochim. Biophys. Acta pmid:28734966
Komura N et al. Syntheses of Fluorescent Gangliosides for the Studies of Raft Domains. 2017 Meth. Enzymol. pmid:28935104
Raghavan SS et al. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures. 1985 Am. J. Hum. Genet. pmid:2934978
Charrow J and Binns HJ Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses. 1986 Clin. Chim. Acta pmid:2938852
Ishikawa Y et al. Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel. 1987 J. Neurochem. pmid:2949061
Harding AE et al. Adult onset supranuclear ophthalmoplegia, cerebellar ataxia, and neurogenic proximal muscle weakness in a brother and sister: another hexosaminidase A deficiency syndrome. 1987 J. Neurol. Neurosurg. Psychiatry pmid:2956362
Eto Y et al. Partial deficiency of beta-hexosaminidase activity in canine GM2-gangliosidosis. 1987 Tohoku J. Exp. Med. pmid:2958961
DeGasperi R et al. A GM2-specific beta-hexosaminidase from the roe of striped mullet (Mugil cephalus). 1988 J. Biol. Chem. pmid:2961751
Ohno K and Suzuki K Mutation in GM2-gangliosidosis B1 variant. 1988 J. Neurochem. pmid:2961848
Budde-Steffen C et al. Presence of beta-hexosaminidase A alpha-chain mRNA in two different variants of GM2-gangliosidosis. 1988 Neuropediatrics pmid:2967444
Tanaka A et al. GM2-gangliosidosis B1 variant: a wide geographic and ethnic distribution of the specific beta-hexosaminidase alpha chain mutation originally identified in a Puerto Rican patient. 1988 Biochem. Biophys. Res. Commun. pmid:2973311
Lichtenberg P et al. Post-partum psychosis in adult GM2 gangliosidosis. A case report. 1988 Br J Psychiatry pmid:2977954
Li SC et al. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide. 1985 J. Biol. Chem. pmid:2981875
Wood PA et al. Fluorescence polarization analysis, lipid composition, and Na+, K+-ATPase kinetics of synaptosomal membranes in feline GM1 and GM2 gangliosidosis. 1985 J. Neurochem. pmid:2983023
Berry-Kravis E and Dawson G Possible role of gangliosides in regulating an adenylate cyclase-linked 5-hydroxytryptamine (5-HT1) receptor. 1985 J. Neurochem. pmid:2997394
Kotagal S Diagnosis of AB variant, GM2 gangliosidosis. 1986 Ann. Neurol. pmid:3080943
Oates CE et al. Movement disorders associated with chronic GM2 gangliosidosis. Case report and review of the literature. 1986 Eur. Neurol. pmid:3081350
Kotagal S et al. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics. 1986 Neurology pmid:3081832
Zeigler M and Bach G Internalization of exogenous gangliosides in cultured skin fibroblasts for the diagnosis of mucolipidosis IV. 1986 Clin. Chim. Acta pmid:3087662
Yanagisawa K et al. Purification and properties of GM2 synthase, UDP-N-acetylgalactosamine: GM3 beta-N-acetylgalactosaminyltransferase from rat liver. 1987 Biochim. Biophys. Acta pmid:3109491
Nagai K and Ishizuka I Biosynthesis of monosulfogangliotriaosylceramide and GM2 by N-acetylgalactosaminyltransferase from rat brain. 1987 J. Biochem. pmid:3115968
Naoi M et al. Ganglioside GM1 causes expression of type B monoamine oxidase in a rat clonal pheochromocytoma cell line, PC12h. 1987 J. Neurochem. pmid:3117976
Naoi M et al. Specific binding of glycosylated beta-galactosidase to rat clonal pheochromocytoma PC12h cells: effects of nerve growth factor and gangliosides. 1988 J. Neurochem. pmid:3126266
Kushi Y et al. Direct analysis of glycolipids on thin-layer plates by matrix-assisted secondary ion mass spectrometry: application for glycolipid storage disorders. 1988 Anal. Biochem. pmid:3149874
Navon R et al. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A. 1985 Am. J. Hum. Genet. pmid:3156493
Kytzia HJ and Sandhoff K Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A. 1985 J. Biol. Chem. pmid:3158659
Jolivet-Reynaud C et al. Damaging effects of Clostridium perfringens delta toxin on blood platelets and their relevance to ganglioside GM2. 1988 Arch. Biochem. Biophys. pmid:3162668
Miyake M et al. Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides. 1988 Cancer Res. pmid:3167861
Yamanaka T et al. Detection of gangliotriaose-series glycosphingolipids in serum of cord blood and patients with neuroblastoma by a sensitive TLC/enzyme-immunostaining method. 1987 Biochim. Biophys. Acta pmid:3300782
Geiger B and Smolarsky M Immunochemical determination of ganglioside GM2, by inhibition of complement-dependent liposome lysis. 1977 J. Immunol. Methods pmid:333030
Torres BV et al. Glycolipid-lectin interactions: reactivity of lectins from Helix pomatia, Wisteria floribunda, and Dolichos biflorus with glycolipids containing N-acetylgalactosamine. 1988 Arch. Biochem. Biophys. pmid:3355161
Livingston PO et al. Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients. 1987 Proc. Natl. Acad. Sci. U.S.A. pmid:3472242
Dawson G et al. Regulation of GM2 ganglioside metabolism in cultured cells. 1986 Chem. Phys. Lipids pmid:3549015
Ando I et al. Ganglioside GM2 on the K562 cell line is recognized as a target structure by human natural killer cells. 1987 Int. J. Cancer pmid:3596830
Rosengren B et al. Composition of gangliosides and neutral glycosphingolipids of brain in classical Tay-Sachs and Sandhoff disease: more lyso-GM2 in Sandhoff disease? 1987 J. Neurochem. pmid:3612128
Wynn CH and Robson B Calculation of the conformation of glycosphingolipids. 2. GM1- and GM2-gangliosides. 1986 J. Theor. Biol. pmid:3626589
Li YT et al. Occurrence of ceramide-glycanase in the earthworm, Lumbricus terrestris. 1987 Biochem. Biophys. Res. Commun. pmid:3689409
Natoli EJ et al. A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity. 1986 Cancer Res. pmid:3731079
Miyagi T and Tsuiki S Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane. 1986 FEBS Lett. pmid:3758350
Livingston PO et al. Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells. 1987 J. Immunol. pmid:3805726
Sugimoto M et al. Total synthesis of gangliosides GM1 and GM2. 1986 Carbohydr. Res. pmid:3815403
Burg J et al. Mapping of the gene coding for the human GM2 activator protein to chromosome 5. 1985 Ann. Hum. Genet. pmid:3865618
Higashi H et al. Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer. 1985 Cancer Res. pmid:3874688
Sonderfeld S et al. Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects. 1985 Eur. J. Biochem. pmid:3922757
Kasai N et al. Preparation and specificity of avian anti-GM2(NeuGc) ganglioside antiserum. 1985 Biochem. Biophys. Res. Commun. pmid:3925943
Ishizuka I et al. Preparation and enzymatic degradation of monosulfogangliotriaosylceramide. 1985 J. Biol. Chem. pmid:3928630
Dahiya R and Brasitus TA Glycosphingolipid patterns of fetal and adult small intestinal mucosa in the sheep. 1986 Biochim. Biophys. Acta pmid:3942764
Raghavan S et al. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis. 1985 Biochim. Biophys. Acta pmid:3995063
Iwamori M et al. Brain gangliosides of quaking and shiverer mutants: qualitative and quantitative changes of monosialogangliosides in the quaking brain. 1985 J. Neurochem. pmid:3998734
Wenger DA Diagnosis of atypical patients with lipid storage diseases. 1985 Brain Dev. pmid:4014607
Cork LC et al. GM2 ganglioside lysosomal storage disease in cats with beta-hexosaminidase deficiency. 1977 Science pmid:404709
Duffard RO et al. Ganglioside composition and biosynthesis in cultred cells derived from CNS. 1977 J. Neurochem. pmid:406360
Sasaki T Glycolipid-binding proteins. 1985 Chem. Phys. Lipids pmid:4064224
Bernheimer H et al. Sandhoff disease: ganglioside G(M2) and asialo-G(M2) accumulation in the cerebrospinal fluid. 1977 J. Neurochem. pmid:407331
Novak A et al. Preparation of radiolabeled GM2 and GA2 gangliosides. 1979 J. Lipid Res. pmid:490046
O'Brien JS and Geiger B Normal adult with absent HEX A: immunoreactive HEX A is present. 1979 Am. J. Hum. Genet. pmid:507054
Young WW et al. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2). 1979 J. Exp. Med. pmid:512581
O'Neill B et al. Adult-onset GM2 gangliosidosis. Seizures, dementia, and normal pressure hydrocephalus associated with glycolipid storage in the brain and arachnoid granulation. 1978 Neurology pmid:568730
Hechtman P and LeBlanc D Purification and properties of the hexosaminidase A-activating protein from human liver. 1977 Biochem. J. pmid:603630
Boggs JM et al. Immune lysis of lipid vesicles containing myelin basic protein or glycolipid antigens by multiple sclerosis and normal sera. J. Neurol. Sci. pmid:6085112
Itoh H et al. The fine structure of cytoplasmic inclusions in brain and other visceral organs in Sandhoff disease. 1984 Brain Dev. pmid:6097133
Schwab ME and Vassella F Synopsis: gangliosidoses. 1984 Neuropediatrics pmid:6100793
Schulte FJ Clinical course of GM2 gangliosidoses. A correlative attempt. 1984 Neuropediatrics pmid:6100797
Pampiglione G and Harden A Neurophysiological investigations in GM1 and GM2 gangliosidoses. 1984 Neuropediatrics pmid:6100798
Di Gregorio F et al. The influence of gangliosides on neurite growth and regeneration. 1984 Neuropediatrics pmid:6100799
Goebel HH Morphology of the gangliosidoses. 1984 Neuropediatrics pmid:6100800
Tai T et al. Ganglioside GM2 as a human tumor antigen (OFA-I-1). 1983 Proc. Natl. Acad. Sci. U.S.A. pmid:6193515
Poulos A et al. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate. 1982 Clin. Chim. Acta pmid:6210469
Conzelmann E et al. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. 1982 Eur. J. Biochem. pmid:6210531
Hasilik A et al. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2. 1982 Eur. J. Biochem. pmid:6214395
Schwerer B et al. Antisera against ganglioside GM2: immunochemical and immunohistological studies. Neuropathol. Appl. Neurobiol. pmid:6214725
Li YT et al. Differentiation of two variants of type-AB GM2-gangliosidosis using chromogenic substrates. 1983 Am. J. Hum. Genet. pmid:6222647
Inui K et al. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein. 1983 Am. J. Hum. Genet. pmid:6224417